{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T01:09:58Z","timestamp":1790125798692,"version":"4.0.1"},"reference-count":18,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.antiviral.2010.11.013","type":"journal-article","created":{"date-parts":[[2010,11,30]],"date-time":"2010-11-30T10:47:42Z","timestamp":1291114062000},"page":"124-126","source":"Crossref","is-referenced-by-count":24,"title":["CpG oligodeoxynucleotides protect against the 2009 H1N1 pandemic influenza virus infection in a murine model"],"prefix":"10.1016","volume":"89","author":[{"given":"Tao","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Qiang","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Juan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Feng","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-Yuan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E-De","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Feng","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2010.11.013_bib0005","doi-asserted-by":"crossref","first-page":"8948","DOI":"10.1128\/JVI.77.16.8948-8956.2003","article-title":"Local delivery of CpG oligodeoxynucleotides induces rapid changes in the genital mucosa and inhibits replication, but not entry, of herpes simplex virus type 2","volume":"77","author":"Ashkar","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2010.11.013_bib0010","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3109\/08820131003674826","article-title":"Induction of cell-mediated immune responses to peptide antigens of P. vivax in microparticles using intranasal immunization","volume":"39","author":"Bhat","year":"2010","journal-title":"Immunol. Invest."},{"key":"10.1016\/j.antiviral.2010.11.013_bib0015","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1099\/vir.0.19029-0","article-title":"An immunostimulatory oligodeoxynucleotide containing a cytidine\u2013guanosine motif protects senescence-accelerated mice from lethal influenza virus by augmenting the T helper type 1 response","volume":"84","author":"Dong","year":"2003","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2010.11.013_bib0020","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1086\/344232","article-title":"Mucosal immunization with inactivated human immunodeficiency virus plus CpG oligodeoxynucleotides induces genital immune responses and protection against intravaginal challenge","volume":"186","author":"Dumais","year":"2002","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2010.11.013_bib0025","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/nature08260","article-title":"In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses","volume":"460","author":"Itoh","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2010.11.013_bib0030","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.antiviral.2006.03.010","article-title":"Protection of Balb\/c mice against infection with FMDV by immunostimulation with CpG oligonucleotides","volume":"72","author":"Kamstrup","year":"2006","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2010.11.013_bib0035","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1080\/08830180600743057","article-title":"Adjuvant activity of CpG oligodeoxynucleotides","volume":"25","author":"Klinman","year":"2006","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.antiviral.2010.11.013_bib0040","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/nrd2059","article-title":"Therapeutic potential of toll-like receptor 9 activation","volume":"5","author":"Krieg","year":"2006","journal-title":"Nat. Rev. Drug. Discov."},{"key":"10.1016\/j.antiviral.2010.11.013_bib0045","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1126\/science.1177238","article-title":"Transmission and pathogenesis of swine-origin 2009 A (H1N1) influenza viruses in ferrets and mice","volume":"325","author":"Maines","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2010.11.013_bib0050","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1128\/JVI.01805-09","article-title":"Prophylactic administration of bacterially derived immunomodulators improves the outcome of influenza virus infection in a murine model","volume":"84","author":"Norton","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2010.11.013_bib0055","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.antiviral.2004.10.004","article-title":"CpG-DNA protects against a lethal orthopoxvirus infection in a murine model","volume":"65","author":"Rees","year":"2005","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2010.11.013_bib0060","doi-asserted-by":"crossref","first-page":"12344","DOI":"10.1128\/JVI.78.22.12344-12354.2004","article-title":"CpG oligodeoxynucleotides block human immunodeficiency virus type 1 replication in human lymphoid tissue infected ex vivo","volume":"78","author":"Schlaepfer","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2010.11.013_bib0065","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/eji.200324032","article-title":"Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities","volume":"34","author":"Vollmer","year":"2004","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.antiviral.2010.11.013_bib0070","doi-asserted-by":"crossref","first-page":"10833","DOI":"10.1073\/pnas.94.20.10833","article-title":"Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization","volume":"94","author":"Weiner","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2010.11.013_bib0075","unstructured":"WHO, 2010. Pandemic (H1N1) 2009-Update 111. Available online: http:\/\/www.who.int\/csr\/don\/2010_07_30\/en\/index.html."},{"key":"10.1016\/j.antiviral.2010.11.013_bib0080","unstructured":"WHO, 2009. Antiviral drugs for pandemic (H1N1) 2009. Available online: http:\/\/www.who.int\/csr\/disease\/swineflu\/frequently_asked_questions\/antivirals\/en\/index.html."},{"key":"10.1016\/j.antiviral.2010.11.013_bib0085","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1016\/j.vaccine.2009.01.048","article-title":"Activation of toll-like receptor signaling pathway for protection against influenza virus infection","volume":"27","author":"Wong","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2010.11.013_bib0090","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1016\/j.vaccine.2005.01.037","article-title":"Prophylaxis of acute respiratory virus infections using nucleic acid-based drugs","volume":"23","author":"Wong","year":"2005","journal-title":"Vaccine"}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354210008168?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354210008168?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T17:27:13Z","timestamp":1559842033000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354210008168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S0166354210008168"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2010.11.013","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}